SBRA
Sabra Health Care REIT, Inc.
Set alert
19.74 USD +0.13 +0.66%
19.70 Day range 19.96
17.47 52-week range 22.39
- YTD
- +4.22%
- 1 year
- +12.99%
- Open
- 19.76
- Prev close
- 19.61
- Mkt cap
- 5.04B
- Vol
- 2.02M
- Avg vol
- 2.40M
- EPS
- 0.25
- P/E
- 78.96
- Div yield
- 6.12%
More statistics
- Low
- 19.70
- High
- 19.96
- Forward P/E
- 24.37
- Beta
- 0.62
- Short ratio
- 6.95
- Inst. own
- 105.25%
- Dividend
- 1.20
- Ex-div date
- Aug 13, 2026
- Earnings
- Nov 2, 2026
- 50-d avg
- 19.89
- 200-d avg
- 19.97
- 1y target
- 22.36
Key statistics
- Market cap
- 5.04B
- Enterprise value
- 7.40B
- Trailing P/E
- 78.96
- Forward P/E
- 24.37
- PEG ratio
- 5.28
- Price / sales
- 5.84
- Price / book
- 1.83
- EPS (TTM)
- 0.25
- Beta
- 0.62
- Dividend yield
- 6.12%
- Payout ratio
- 480.00%
- Profit margin
- 7.58%
- Revenue (TTM)
- 863.77M
- Revenue growth
- 25.30%
- Free cash flow
- 155.12M
- Total cash
- 246.31M
- Total debt
- 2.63B
- Return on equity
- 2.39%
- Shares outstanding
- 255.46M
- Short % of float
- 9.51%
- 50-day average
- 19.89
- 200-day average
- 19.97
Analyst view
Consensus: buy
Buy
Price target (mean) 22.36 +13.3% upside
Now 19.74
- Target (low)
- 19.00
- Target (mean)
- 22.36
- Target (high)
- 25.00
Ratings (0m) 16 6 buy · 10 hold · 0 sell
- Strong buy1
- Buy5
- Hold10
- Sell0
- Strong sell0
Next earnings
Nov 2, 2026
Expected Nov 2, 2026. Consensus EPS estimate 0.165.
Financials — quick view
SBRA Revenue — quarterly 235.87M
SBRA Net income — quarterly -25.20M
SBRA EPS — quarterly -0.10
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 2, 2026 | Sep 30, 2026 | 0.1637 | — | — | — |
| Aug 3, 2026 | Jun 30, 2026 | 0.1711 | -0.10 | -0.27 | -158.45% |
| Apr 29, 2026 | Mar 31, 2026 | 0.1667 | 0.16 | -0.01 | -4.02% |
| Feb 12, 2026 | Dec 31, 2025 | 0.17 | 0.11 | -0.06 | -35.29% |
| Nov 5, 2025 | Sep 30, 2025 | 0.1834 | 0.094 | -0.09 | -48.75% |
| Aug 4, 2025 | Jun 30, 2025 | 0.18 | 0.28 | +0.10 | +55.56% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 19, 2026 | Wells Fargo | main | Overweight | Overweight |
| Oct 13, 2026 | UBS | main | Neutral | Neutral |
| Oct 13, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
| Aug 31, 2026 | Barclays | main | Equal-Weight | Equal-Weight |
| Aug 31, 2026 | Baird | main | Neutral | Neutral |
| Aug 6, 2026 | Raymond James | up | Underperform | Market Perform |
About Sabra Health Care REIT, Inc.
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- Country
- United States
- Website
- sabrahealth.com
News
- Senior Housing Demand Is Rising. Can These 4 REITs Turn It Into Bigger Dividends?
- The Aging Boomer Landlords: 5 Senior Housing REITs and What Their Yields Are Telling You
- PEB vs. SBRA: Which Stock Is the Better Value Option?
- Sabra Health Care REIT, Inc. Announces Third Quarter 2026 Earnings Release Date and Conference Call
- Wells Fargo Maintains Overweight on Sabra Health Care REIT, Lowers Price Target to $21
- Discovery Senior Living Acquires Sunshine Retirement Living, Expanding National Operating Platform and Establishing Strategic Pacific Northwest Presence
- UBS Maintains Neutral on Sabra Health Care REIT, Lowers Price Target to $20
- Barclays Maintains Equal-Weight on Sabra Health Care REIT, Lowers Price Target to $21
- Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Stock Rated “Moderate Buy” by Wall Street Brokerages
- Sabra Healthcare REIT, Inc. $SBRA Stock Sold by Squarepoint Ops LLC
Your note
Sign in to keep a note on SBRA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARBAROSH CRAIG A | Director | Stock Award(Grant) | Aug 30, 2026 | 159,033 |
| COSTA MICHAEL LOURENCO | Chief Financial Officer | Stock Award(Grant) | Aug 30, 2026 | 470,870 |
| CUSACK CATHERINE | Director | Stock Award(Grant) | Aug 30, 2026 | 82,847 |
| FLORES JESSICA | Officer | Stock Award(Grant) | Aug 30, 2026 | 72,476 |
| FOSTER MICHAEL JEFFREY | Director | Stock Award(Grant) | Aug 30, 2026 | 125,246 |
| KATZMANN LYNNE S. | Director | Stock Award(Grant) | Aug 30, 2026 | 86,912 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.29% | 41,614,351 | 821.47M | Jun 29, 2026 |
| Principal Financial Group, Inc. | 9.67% | 24,706,070 | 487.70M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 9.14% | 23,352,373 | 460.98M | Jun 29, 2026 |
| State Street Corporation | 4.82% | 12,305,655 | 242.91M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.44% | 11,349,125 | 224.03M | Jun 29, 2026 |
| Geode Capital Management, LLC | 3.10% | 7,909,172 | 156.13M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Real Estate Index Fund | 3.75% | 9,591,242 | 189.33M | Jul 30, 2026 |
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 9,099,666 | 179.63M | Sep 29, 2026 |
| Principal Funds, Inc-Real Estate Securities Fund | 3.24% | 8,264,998 | 163.15M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.13% | 8,001,962 | 157.96M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.61% | 6,655,161 | 131.37M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.26% | 5,786,194 | 114.22M | Jun 29, 2026 |